NEXT GENERATION BIOLOGICS FOR DENTISTRY
Summit Biologics is committed to bringing unique and first to market biomaterials to the North American market. Areas of innovation include 3DI surface technology that promotes highly inductive bone cell differentiation without the use of expensive growth factors, novel soft tissue regenerative agents such as hyaluronic acid, and safer barrier membranes fabricated from atelo-collagen reducing the potential for foreign body reactions . These technologies have been extensively researched and many are currently being utilized in various other dental markets such as Europe or orthopedics with major success. We are constantly researching new and novel ways to promote healing, decrease complications and improve patient experience. We continue to invest in high quality clinical research to provide our clients with a pipeline of new and exciting innovative biomaterials.